MedTrace Logo

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

NCT00006050 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-02-17

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of liver perfusion using oxaliplatin plus leucovorin and fluorouracil given by infusion in treating patients who have colorectal cancer that has spread to the liver.

Conditions

Interventions

DRUG

FOLFOX regimen

DRUG

fluorouracil

DRUG

isolated perfusion

DRUG

leucovorin calcium

DRUG

oxaliplatin

Sponsors & Collaborators

  • UNICANCER

    lead OTHER

Principal Investigators

  • Michel Ducreux, MD, PhD · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Purpose
TREATMENT

Eligibility

Min Age
0 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-04-04
Primary Completion
2001-12-31
Completion
2003-04-04

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006050 on ClinicalTrials.gov